From Tuesday Generex Conference Call - 15 October
Post# of 36507
![](/assets/46931549/no_avatar_available_thumb.jpg)
See: https://www.generex.com/
"So, we've decided to rights to offering with NuGenerex Immuno-Oncology to Generex's shareholders. The right to offer would be offered to our shareholders a very appealing and beneficial rate, with the proceeds to be used for operations, clinical trials, and immediately comply with the NASDAQ listing " - CEO GENEREX
Got it right? Will NGIO be listed on Nasdaq? If true, that's great news!
Thanks Generex TEAM!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)